RPFCX Performance — Davis Balanced Fund, Class A
Data updated: 2026-08-27
RPFCX returned +11.27% year to date and +23.08% over one year to Jun 2026. Annualised returns are +19.72% over 3 years and +11.08% over 5 years. The fund beat its US Large Blend category average: $100 invested three years ago grew to $172, against $157 for the category, and to $123 over one year, against $118. Volatility over the past three years was 10.67% a year. In the 12 months to Jun 2026 the fund took in a net $4.5M, and assets reached $319.16M.
RPFCX Growth of $100
What $100 invested in Davis Balanced Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Blend category average over the same months.
| Period | RPFCX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $123 | $118 |
| 3 years (Jul 2023 – Jun 2026) | $172 | $157 |
| 5 years (Jul 2021 – Jun 2026) | $169 | $161 |
| Since data start (Jul 2019 – Jun 2026) | $232 | $229 |
RPFCX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +11.27% |
| 1 year | +23.08% |
| 3 years (annualised) | +19.72% |
| 5 years (annualised) | +11.08% |
RPFCX Annual Returns
Calendar-year total returns of Davis Balanced Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +11.27% |
| 2025 | +21.37% |
| 2024 | +15.87% |
| 2023 | +22.97% |
| 2022 | −15.64% |
| 2021 | +25.72% |
| 2020 | +4.75% |
| 2019 (Jul–Dec) | +8.31% |
RPFCX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.5% | +2.6% | −4.3% | +6.4% | +0.7% | +3.1% | — | — | — | — | — | — |
| 2025 | +5.9% | −0.3% | −2.4% | −0.8% | +2.6% | +4.4% | −1.2% | +4.4% | +0.6% | +0.9% | +3.9% | +1.7% |
| 2024 | +1.3% | +5.0% | +3.1% | −2.4% | +3.4% | +0.1% | +2.3% | +0.9% | +0.5% | −0.7% | +6.3% | −4.4% |
| 2023 | +7.5% | −2.5% | −1.1% | +1.6% | +1.0% | +5.6% | +4.4% | −2.1% | −3.3% | −1.3% | +6.2% | +5.9% |
| 2022 | −1.3% | −2.8% | −0.1% | −8.1% | +2.6% | −9.9% | +6.1% | −3.9% | −7.3% | +6.9% | +6.9% | −4.1% |
| 2021 | +1.4% | +6.5% | +4.9% | +4.8% | +2.1% | −0.5% | +0.7% | +2.2% | −2.4% | +3.2% | −2.6% | +3.2% |
| 2020 | −1.6% | −6.1% | −16.1% | +9.3% | +2.1% | +1.4% | +2.4% | +4.1% | −3.0% | −0.3% | +12.1% | +3.3% |
| 2019 | — | — | — | — | — | — | +1.2% | −2.8% | +3.6% | +1.3% | +2.5% | +2.3% |
RPFCX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 10.67%
- 3-year Sharpe ratio: 1.43 (vs 4.5% risk-free rate)
- Best month: +6.41% (Apr 2026)
- Worst month: −4.39% (Dec 2024)
RPFCX Fund Flows
Monthly money in and out of Davis Balanced Fund, from SEC Form N-PORT.
- 12-month net flow: $4.5M
- 12-month gross sales (incl. reinvestments): $46.5M
- Sales ÷ redemptions: 1.11×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $3.3M | $2.8M | $459K |
| May 2026 | $2.7M | $3.0M | −$309K |
| Apr 2026 | $3.4M | $3.9M | −$580K |
| Mar 2026 | $4.1M | $4.0M | $146K |
| Feb 2026 | $2.9M | $2.4M | $471K |
| Jan 2026 | $2.9M | $11.6M | −$8.7M |
| Dec 2025 | $19.5M | $4.4M | $15.1M |
| Nov 2025 | $2.1M | $1.7M | $318K |
| Oct 2025 | $1.4M | $1.8M | −$326K |
| Sep 2025 | $1.9M | $2.5M | −$626K |
| Aug 2025 | $686K | $1.6M | −$899K |
| Jul 2025 | $1.6M | $2.1M | −$477K |
RPFCX Assets Under Management
Net assets of Davis Balanced Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $319.16M |
| 2026-03-31 | $291.03M |
| 2025-12-31 | $296.66M |
| 2025-09-30 | $278.96M |
| 2025-06-30 | $271.82M |
| 2025-03-31 | $258.64M |
| 2024-12-31 | $249.23M |
| 2024-09-30 | $255.03M |
| 2024-06-28 | $247.63M |
| 2024-03-31 | $249.18M |
| 2023-12-31 | $220.04M |
| 2023-09-30 | $198.20M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.